KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. (Q48557897)
Jump to navigation
Jump to search
scientific article published on 3 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. |
scientific article published on 3 May 2006 |
Statements
1 reference
KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. (English)
1 reference
Christine Bellanné-Chantelot
1 reference
Andrew T Hattersley
1 reference
Catherine Diatloff-Zito
1 reference
Emma L Edghill
1 reference
Sylvie Nivot
1 reference
Régis Coutant
1 reference
Jean Jacques Robert
1 reference
3 May 2006
1 reference
14
1 reference
7
1 reference
824-830
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference